Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nature ; 491(7425): 566-9, 2012 Nov 22.
Article in English | MEDLINE | ID: mdl-23172214

ABSTRACT

Pluto and Eris are icy dwarf planets with nearly identical sizes, comparable densities and similar surface compositions as revealed by spectroscopic studies. Pluto possesses an atmosphere whereas Eris does not; the difference probably arises from their differing distances from the Sun, and explains their different albedos. Makemake is another icy dwarf planet with a spectrum similar to Eris and Pluto, and is currently at a distance to the Sun intermediate between the two. Although Makemake's size (1,420 ± 60 km) and albedo are roughly known, there has been no constraint on its density and there were expectations that it could have a Pluto-like atmosphere. Here we report the results from a stellar occultation by Makemake on 2011 April 23. Our preferred solution that fits the occultation chords corresponds to a body with projected axes of 1,430 ± 9 km (1σ) and 1,502 ± 45 km, implying a V-band geometric albedo p(V) = 0.77 ± 0.03. This albedo is larger than that of Pluto, but smaller than that of Eris. The disappearances and reappearances of the star were abrupt, showing that Makemake has no global Pluto-like atmosphere at an upper limit of 4-12 nanobar (1σ) for the surface pressure, although a localized atmosphere is possible. A density of 1.7 ± 0.3 g cm(-3) is inferred from the data.

2.
Child Psychiatry Hum Dev ; 47(5): 792-8, 2016 10.
Article in English | MEDLINE | ID: mdl-26658937

ABSTRACT

Recently, social anxiety disorder (SAD) and paranoia have been demonstrated to be closely related. However, data were primarily drawn from adult community samples or patients with schizophrenia. The present study used a cross-sectional design to evaluate a sample of adolescents with SAD (n = 30, mean age 15.3 ± 0.9 years) compared with an age- and sex-matched group of healthy controls (n = 26, mean age 15.9 ± 1.6 years). The SAD group displayed more frequent and intense paranoid thoughts than the control group (t = 4.16, p < 0.001). The level of paranoid thoughts was significantly predicted by the degree of social phobia, even after adjusting for sex and other anxiety disorders, although adjusting for depression slightly reduced the extent and significance of the prediction. A lack of awareness about the association between SAD and paranoia may lead to incorrect diagnoses (e.g. misdiagnosis of psychotic disorders), or it may negatively influence the (psycho)therapeutic process and patient outcomes.


Subject(s)
Anxiety Disorders , Depression , Paranoid Disorders , Phobia, Social , Adolescent , Age Factors , Anxiety Disorders/diagnosis , Anxiety Disorders/epidemiology , Anxiety Disorders/psychology , Cross-Sectional Studies , Depression/diagnosis , Depression/psychology , Female , Humans , Italy/epidemiology , Male , Paranoid Disorders/diagnosis , Paranoid Disorders/psychology , Phobia, Social/diagnosis , Phobia, Social/psychology , Psychiatric Status Rating Scales , Psychotherapeutic Processes , Sex Factors , Social Environment , Statistics as Topic
3.
G Chir ; 36(3): 117-21, 2015.
Article in English | MEDLINE | ID: mdl-26188756

ABSTRACT

In the present study the authors, after a short historical description of the Basedow-Graves' disease, describe their case-study gathered over the last five years. They mention the most widely accepted hypothesis regarding disease's etiology, strongly linked to autoimmune disorders, and the role that some viral agents (Coksackie B and HTLV-II) may have in initiating autoantibody production and T cells activation in genetically predisposed individuals. Basic and clinical aspects of the diagnosis and disease treatment, highlighting the use of thyroidectomy, are addressed. They conclude that total thyroidectomy represents today the treatment of choice, which, after appropriate preparation to reach the euthyroidism condition, can ensure a successful cure.


Subject(s)
Graves Disease/surgery , Thyroidectomy , Adolescent , Adult , Antithyroid Agents/therapeutic use , Female , Graves Disease/drug therapy , Humans , Male , Middle Aged , Retrospective Studies , Thyroidectomy/methods , Treatment Outcome
4.
Biochim Biophys Acta ; 1345(3): 338-48, 1997 Apr 21.
Article in English | MEDLINE | ID: mdl-9150253

ABSTRACT

Cannabinoid receptors have been described in sea urchin sperm and shown to mediate inhibition of sperm acrosome reaction. Anandamide (arachidonoyl-ethanolamide), the mammalian physiological ligand at the cannabinoid CB1 receptor, has been subsequently found to effect this inhibition. Here we present data showing that ovaries from the sea urchin Paracentrotus lividus contain anandamide and two related acyl-ethanolamides, as well as enzymatic activities potentially responsible for their biosynthesis and degradation. Pilot experiments carried out with either ovaries or spermatozoa, extracted from both P. lividus and Arbacea lixula and radiolabelled with [14C]ethanolamine, showed that in sexually mature ovaries of both species significant levels of radioactivity were incorporated into a lipid component with the same chromatographic behaviour as anandamide. Lipid extracts from P. lividus ovaries were purified and analysed by gas chromatography/mass spectrometry which showed the presence of low but measurable amounts of anandamide, palmitoyl- and stearoyl-ethanolamides. The extracts were also found to contain lipid components with the same chromatographic behaviour as the N-acyl-phosphatidyl-ethanolamines, the phospholipid precursors of acyl-ethanolamides in mammalian tissues, and capable of releasing anandamide, palmitoyl- and stearoyl-ethanolamides upon digestion with S. chromofuscus phospholipase D. Accordingly, whole homogenates from P. lividus contained an enzymatic activity capable of converting synthetic [3H]N-arachidonoyl-phosphatidyl-ethanolamine into [3H]anandamide. Finally, mature ovaries of P. lividus were shown also to contain an amidohydrolase activity which catalyses the hydrolysis of anandamide and palmitoyl-ethanolamide to ethanolamine. This enzyme displayed subcellular distribution, pH/temperature dependency profiles and sensitivity to inhibitors similar but not identical to those of the previously described 'anandamide amidohydrolase' from mammalian tissues. These data support the hypothesis, formulated in previous studies, that anandamide or related metabolites may be oocyte-derived cannabimimetic regulators of sea urchin fertility.


Subject(s)
Arachidonic Acids/biosynthesis , Ovary/metabolism , Sea Urchins/physiology , Amidohydrolases/metabolism , Animals , Biological Evolution , Endocannabinoids , Ethanolamine , Ethanolamines/metabolism , Female , Polyunsaturated Alkamides , Reproduction
5.
J Clin Endocrinol Metab ; 86(6): 2687-96, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11397872

ABSTRACT

Little is known about the expression and function of cannabinoid receptor type 1 (CB1) in the human pituitary gland. The aim of this study was to investigate CB1 expression in human normal and tumoral pituitaries by in situ hybridization and immunohistochemistry using an antibody against CB1. CB1 was found in corticotrophs, mammotrophs, somatotrophs, and folliculostellate cells in the anterior lobe of normal pituitary. After examination of 42 pituitary adenomas, CB1 was detected in acromegaly-associated pituitary adenomas, Cushing's adenomas, and prolactinomas, whereas faint or no expression was found in nonfunctioning pituitary adenomas. Experiments with cultured pituitary adenoma cells showed that the CB1 agonist WIN 55,212--2 inhibited GH secretion in most of acromegaly-associated pituitary adenomas tested and that the CB1 antagonist SR 141716A was generally able to reverse this effect. Moreover, WIN 55,212--2 was able to suppress GHRH-stimulated GH release, and this effect was not blocked by coincubation with SR 141716A, possibly indicating a non-CB1-mediated effect. In contrast, WIN 55,212--2 was ineffective on GH-releasing peptide-stimulated GH release. In four Cushing's adenomas tested, WIN 55,212--2 was not able to modify basal ACTH secretion. However, simultaneous application of CRF and WIN 55,212--2 resulted in a synergistic effect on ACTH secretion, and this effect could be abolished by SR 141716A, demonstrating a CB1-mediated effect. In the single case of prolactinomas tested, WIN 55,212--2 was able to inhibit basal secretion of PRL. Finally, the presence of endocannabinoids (anandamide and 2-arachidonoylglycerol) was investigated in normal and tumoral pituitaries. All tumoral samples had higher contents of anandamide and 2-arachidonoylglycerol compared with the normal hypophysis. Moreover, endocannabinoid content in the different pituitary adenomas correlated with the presence of CB1, being elevated in the tumoral samples positive for CB1 and lower in the samples in which no or low levels of CB1 were found. The results of this study point to a direct role of cannabinoids in the regulation of human pituitary hormone secretion.


Subject(s)
Adenoma/metabolism , Cannabinoids/biosynthesis , Pituitary Gland/metabolism , Pituitary Neoplasms/metabolism , Receptors, Drug/metabolism , Adenoma/pathology , Adolescent , Adult , Aged , Cannabinoid Receptor Modulators , Cannabinoids/metabolism , Cannabinoids/pharmacology , Female , Hormones/metabolism , Humans , Male , Middle Aged , Pituitary Neoplasms/pathology , Receptors, Cannabinoid , Reference Values , Tumor Cells, Cultured
6.
Neuroscience ; 92(1): 377-87, 1999.
Article in English | MEDLINE | ID: mdl-10392859

ABSTRACT

Hydra (Cnidaria) is the first animal organism to have developed a neural network, which has been proposed to control, inter alia, the "feeding response", i.e. a mechanism through which the coelenterate opens and then closes its mouth in the presence of prey and/or glutathione. Here, we report that Hydra contains: (i) selective cannabinoid binding sites; (ii) the endogenous cannabinoid receptor ligand, anandamide (arachidonoylethanolamide); (iii) a fatty acid amide hydrolase-like activity catalysing anandamide hydrolysis; and (iv) the putative biosynthetic precursor of anandamide, N-arachidonoylphosphatidylethanolamine. We suggest that this "endogenous cannabinoid system" is involved in the modulation of the "feeding response". Anandamide (1 nM-1 microM) potently inhibited (up to 45%) the glutathione-induced "feeding response" by accelerating Hydra vulgaris mouth closure. The effect was maximal at 100 nM anandamide and was reversed by the selective antagonist of the CB1 subtype of mammalian cannabinoid receptors, SR 141716A (50-100 nM). Specific cannabinoid binding sites were detected in membranes from Hydra polyps by using [3H]SR 141716A (Kd= 1.87 nM, Bmax = 26.7 fmol/mg protein), and increasing anandamide concentrations were found to displace the binding of [3H]SR 141716A to these membranes (Ki = .505 nM). Hydra polyps were also found to contain amounts of anandamide (15.6 pmol/g) and N-arachidonoylphosphatidylethanolamine (32.4 pmol/g), as well as the other "endocannabinoid" 2-arachidonoylglycerol (11.2 nmol/g), comparable to those described previously for mammalian brain. Finally, a fatty acid amide hydrolase activity (Vmax = 3.4 nmol/min/mg protein), with subcellular distribution, pH dependency and sensitivity to inhibitors similar to those reported for the mammalian enzyme, but with a lower affinity for anandamide (Km = 400 microM), was also detected in Hydra polyps. These data suggest that the endocannabinoid signalling system plays a physiological role in Hydra that is to control the feeding response. Hydra is the simplest living organism described so far to use this recently discovered regulatory system.


Subject(s)
Arachidonic Acids/metabolism , Cannabinoids/metabolism , Eating/physiology , Hydra/physiology , Receptors, Drug/physiology , Signal Transduction/physiology , Amidohydrolases/metabolism , Animals , Arachidonic Acids/pharmacology , Binding Sites/physiology , Cannabinoid Receptor Modulators , Eating/drug effects , Endocannabinoids , Glutathione/pharmacology , Hydra/metabolism , Hydrolysis , Ligands , Polyunsaturated Alkamides , Protein Precursors/metabolism , Receptors, Cannabinoid
7.
Neuroreport ; 12(10): 2125-9, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11447320

ABSTRACT

Recent studies have demonstrated a loss of cannabinoid CB1 receptors in the basal ganglia in Huntington's disease (HD), but there are no data on endocannabinoid levels in this disease. In the present study, we have addressed this question by using rats with bilateral intrastriatal injections of 3-nitropropionic acid (3-NP), a toxin that, through the selective damage of striatal GABAergic efferent neurons, produces a useful model of HD. Twelve days after the lesion, 3-NP-lesioned rats exhibited motor disturbances, characterized by an ambulatory hyperactivity accompanied by a loss of guided activities. Analysis of GABA contents in the basal ganglia showed a trend towards a reduction compatible with motor hyperactivity. In addition, CB1 receptor binding and, to a greater extent, CB1 receptor activation of GTP-binding proteins, were also reduced in the basal ganglia. These changes were paralleled by a decrease of the contents of the two endocannabinoids, anandamide and 2-arachidonoylglycerol, in the striatum, and by an increase, particularly of anandamide, in the ventral mesencephalon where the substantia nigra is located. Both CB1 receptors and endocannabinoid levels were not altered in the cerebral cortex, an area not affected by the lesion. In summary, behavioral and biochemical changes observed in rats intrastriatally lesioned with 3-NP were similar to those occurring in the brain of HD patients. As expected, a loss of CB1 receptor function was evident in the basal ganglia of these rats and this was accompanied by different changes in endocannabinoid levels.


Subject(s)
Basal Ganglia/physiopathology , Cannabinoids/metabolism , Disease Models, Animal , Huntington Disease/metabolism , Synaptic Transmission/physiology , Animals , Cannabinoid Receptor Modulators , Convulsants/administration & dosage , Endocannabinoids , Huntington Disease/chemically induced , Huntington Disease/physiopathology , Injections, Intraventricular , Male , Motor Activity/drug effects , Nitro Compounds , Propionates/administration & dosage , Rats , Rats, Sprague-Dawley , Receptors, Cannabinoid , Receptors, Drug/drug effects , Receptors, Drug/metabolism , gamma-Aminobutyric Acid/metabolism
8.
Eur J Pharmacol ; 420(2-3): 123-31, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11408034

ABSTRACT

Capsaicin and its analogue N-arachidonoyl-vanillyl-amine (arvanil) are agonists of vanilloid VR1 receptors, and suppress spontaneous activity in mice through an unknown mechanism. Here, we tested in rats the effect on motor behavior of: (1) capsaicin; (2) N-linoleoyl-vanillyl-amine (livanil) and N-alpha-linolenoyl-vanillyl-amine (linvanil), which, unlike arvanil, have very little affinity for cannabinoid CB1 receptors; and (3) the endocannabinoid anandamide (N-arachidonoyl-ethanolamine), which is a full agonist at both cannabinoid CB1 and vanilloid VR1 receptors. All compounds, administered i.p., dose-dependently (0.1-10 mg/kg) inhibited ambulation and stereotypic behavior and increased inactivity in the open field test. The rank of potency observed in vivo (livanil>capsaicin>linvanil>anandamide) bore little resemblance with the relative potencies in a functional assay for rat vanilloid VR1 receptors (livanil=linvanil>capsaicin>anandamide) and even less with the relative affinities in rat CB1 receptor binding assays (anandamide>livanil>linvanil>capsaicin). The vanilloid VR1 receptor antagonist capsazepine (10 mg/kg, i.p.) blocked the effect of capsaicin but not of livanil or anandamide, whereas the CB1 receptor antagonist (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide.HCl (SR141716A, 3 mg/kg, i.p.) antagonized the actions of the CB1 receptor agonist Delta9-tetrahydrocannabinol, but not of livanil, anandamide or capsaicin. Anandamide occluded the effects of livanil on locomotion, possibly suggestive of a common mechanism of action for the two compounds. Finally, stimulation with capsaicin of cells expressing rat vanilloid VR1 receptors led to anandamide formation. These data suggest that motor behavior can be suppressed by the activation of: (1) vanilloid receptors, possibly via the intermediacy of anandamide; or (2) capsazepine- and SR141716A-insensitive sites of action for anandamide, livanil and linvanil, possibly the same that were previously suggested to mediate arvanil hypokinetic effects in mice.


Subject(s)
Capsaicin/pharmacology , Motor Activity/drug effects , Animals , Arachidonic Acids/biosynthesis , Behavior, Animal/drug effects , Binding, Competitive , Cannabinoid Receptor Modulators , Capsaicin/analogs & derivatives , Capsaicin/metabolism , Cell Line , Dose-Response Relationship, Drug , Endocannabinoids , Humans , Polyunsaturated Alkamides , Rats , Receptors, Cannabinoid , Receptors, Drug/genetics , Receptors, Drug/metabolism , Stereotyped Behavior/drug effects , Transfection
9.
Life Sci ; 58(14): 1101-8, 1996.
Article in English | MEDLINE | ID: mdl-8614261

ABSTRACT

We have recently shown that ascorbate has a hypocholesterolemic and hypotriglyceridemic effect on rats fed a diet enriched with 1.5% cholesterol and 25% hydrogenated coconut oil (Nath diet). In this study we evaluated the effect of intraperitoneal ascorbate administration on susceptibility to lipoperoxidation either in rats fed standard or Nath diet. In normal rats ascorbate treatment decreased (p<0.05) the susceptibility to lipoperoxidation induced by incubation of serum for 24 hours with 2.2 mM Cu++, without altering the normal serum fatty acid profile. In rats fed Nath diet we observed a reduced susceptibility of serum to CU++-induced lipoperoxidation (36%), according with their low levels of serum unsaturated fatty acids (40% less than rats fed standard diet). In these animals ascorbate administration affects serum fatty acid profile leading to a decrease of S/U ratio from 1.6 to 1.2 without significantly modifying the susceptibility of serum to lipoperoxidation. Moreover, the production of spontaneous lipid peroxides in liver homogenates, measured as TBARS levels, was strongly inhibited by ascorbate (p<0.01) in rats fed either standard or Nath diet. These data indicate that ascorbate administration exerts an antioxidant effect and that in hypercholesterolemic rats, in addition to a lipid lowering effect, ascorbate exerts a protective role against the peroxidative damage of lipids.


Subject(s)
Ascorbic Acid/therapeutic use , Cholesterol, Dietary/adverse effects , Hypercholesterolemia/prevention & control , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Animals , Ascorbic Acid/blood , Body Weight/drug effects , Copper/blood , Copper/pharmacology , Copper Sulfate , Fatty Acids/blood , Hypercholesterolemia/blood , Hypercholesterolemia/metabolism , Lipid Peroxides/blood , Male , Rats , Rats, Wistar
10.
Panminerva Med ; 40(3): 254-7, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9785928

ABSTRACT

A 15 year-old adolescent boy with a severe treatment refractory bipolar disorder type I, most recent episode manic, severe with psychotic features had previously required hospitalizations and treatment with lithium and/or carbamazepine and high doses of standard neuroleptics without any response. A treatment with a combined clozapine-lithium therapy was progressively started in a hospital setting (clozapine 300 mg/day; lithium 1350 mg/day). After 15 days a dramatic improvement in mood and psychotic symptoms was evident. After four weeks there was 50% improvement on the BPRS (from 74 to 37). The mean CGAS score changed from 25 to 72. At the CGI-Severity of Illness subscale, a 57% decrease was evident; at the CGI-Global Improvement subscale there was a 75% increase. The only significant side effects were sedation and fatigue, but they were not so severe as to induce a reduction of dosage. The boy was discharged from the hospital after three weeks and successfully returned to school with no modifications in treatment. After a nine-month treatment there was no reoccurrence of psychotic or manic symptoms. The implications of pharmacological therapy in treatment refractory manic episodes with psychotic features are discussed.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Clozapine/therapeutic use , Adolescent , Drug Therapy, Combination , Humans , Lithium/therapeutic use , Male
11.
Article in English | MEDLINE | ID: mdl-11007181

ABSTRACT

The lipophylic extract from a Black Sea bacterium, associated with the sponge Dysidea fragilis, was investigated. Saturated hydrocarbons and fatty acids of the lipids were identified. The concentrations of the polycyclic compounds appeared to be negligible. The main components appeared to be phosphatidyl ethanolamine, followed by phosphatidyl serine. The first was investigated by FAB mass spectrometry and a series of molecular species partially identified.


Subject(s)
Alteromonas/metabolism , Fatty Acids/metabolism , Hydrocarbons/metabolism , Lipid Metabolism , Porifera/metabolism , Pseudomonas/metabolism , Animals , Ethanolamines/metabolism , Symbiosis
12.
Ann Ital Chir ; 74(2): 177-9; discussion 179-80, 2003.
Article in Italian | MEDLINE | ID: mdl-14577114

ABSTRACT

The vascular lesions in hernia surgery are difficult to be found: on the basis of three cases personally treated and on literature data, the authors dwell upon the factors that influence the frequency of this event, they discuss about the therapeutic choices and they illustrate the short and long term prognosis.


Subject(s)
Femoral Artery/injuries , Hernia, Inguinal/surgery , Intraoperative Complications/etiology , Adult , Anastomosis, Surgical , Humans , Iliac Artery/injuries , Iliac Vein/injuries , Ischemia/etiology , Leg/blood supply , Male , Middle Aged , Recurrence , Sutures/adverse effects
13.
G Chir ; 22(8-9): 269-72, 2001.
Article in Italian | MEDLINE | ID: mdl-11682960

ABSTRACT

AIMS: To evaluate the advantages and limits of one day surgery operations performed between January 1990 and December 2000. METHODS: Pre-operative study of out patients with indications to surgical treatment with short-stay hospitalisation and research of criteria of feasibility of day-surgical program: a) morning hospitalisation; b) surgical intervention; c) post-operative control; d) night control; e) careful evaluation of admission 24 hour after operation and instruction for house-therapy; f) program of follow-up (7 and 14 days after operation). RESULTS: Mortality 0%; immediate post-operative complications 1.8%; post-operative sequelae (one year after surgery): 0.5%; high satisfaction gradient of patients one year after treatment: 89%. DISCUSSION: The Day-Surgery seems to be, after ten years of experience, available in high number of patients, with progressive extension of indications to ever more surgical fields and results very satisfactory, in term of cost-effectiveness too, with an high compliance of the patients to surgical program.


Subject(s)
Ambulatory Surgical Procedures , Adolescent , Adult , Aged , Aged, 80 and over , Feasibility Studies , Female , Humans , Male , Middle Aged
14.
J Affect Disord ; 159: 53-5, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24679389

ABSTRACT

BACKGROUND: The clinical presentation of bipolar disorders, though clearly recognized in adolescents, remains controversial in younger children and across cultures. The aim of this study was to compare the clinical presentation of bipolar disorders in Italian and American children between ages 5 and 12 years. METHODS: Sixty-seven children from six outpatient programs were enrolled (Italian sample: n=40; American sample: n=28) between January 2010 and June 2011. Children and their parents were interviewed by experienced clinicians using the Washington University in St. Louis Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present, Lifetime Version (WASH-U K-SADS). RESULTS: Italian children scored significantly higher on ratings of "elevated mood" (p=0.002), whereas American children scored significantly higher on ratings of "flight of ideas" (p=0.001) and "productivity" (p=0.001). Rates of comorbidity were different between groups. LIMITATIONS: Data were acquired from several sites in Italy as compared to from a single American site. Medication and educational information were not systematically collected. Furthermore, the sample collected may only reflect characteristics of a less severely ill group of bipolar children. CONCLUSIONS: Our comparison of Italian and American children with early onset bipolar disorders found that the phenotype of bipolar spectrum disorders is largely shared across cultures, although psychiatric comorbidities differed.


Subject(s)
Bipolar Disorder/epidemiology , Bipolar Disorder/psychology , Cross-Cultural Comparison , Child , Child, Preschool , Comorbidity , Female , Humans , Interview, Psychological , Italy/epidemiology , Male , United States/epidemiology
20.
Biomed Environ Mass Spectrom ; 13(9): 477-82, 1986 Sep.
Article in English | MEDLINE | ID: mdl-2946336

ABSTRACT

We report an investigation of the effect of the addition of strong mineral acids to the most commonly used matrices for fast atom bombardment mass spectrometry of peptides. Among the acids tested we found that perchloric acid has a beneficial effect on: the sensitivity, the stability of quasi-molecular ion signals. Furthermore, in the presence of basic residues, ions related to perchlorate adducts are present. These further signals may be useful in differentiating peptides containing lysine from those containing the isobaric glutamine.


Subject(s)
Acids/analysis , Peptides/analysis , Chemical Phenomena , Chemistry , Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL